You are here: Home › Resource Center for Research › Funding Opportunity Announcements › Identifying Non-coding RNA Targets for Early Detection of Cancer (R01): PA-12-213

Identifying Non-coding RNA Targets for Early Detection of Cancer (R01): PA-12-213

http://grants.nih.gov/grants/guide/pa-files/PA-12-213.html

FOA Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research projects on non-coding RNAs (ncRNAs) and their targets in preneoplastic lesions and early stage cancers. This FOA also encourages research projects to assess the usefulness of stable microRNAs (miRNAs) and ncRNAs to predict progression to cancer and as biomarkers for early cancer detection and screening. Building on both basic and biomarker research on microRNAs (miRNA), this FOA will further promote research on all classes of ncRNAs and support the translation of stable miRNAs into cancer screening or diagnostic tests.

Letter of Intent Due Date: Not Applicable

Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.

Expiration Date: September 8, 2015

Funding

The project is supported by grant 8U54MD007587-03 (RCMI Clinical and Translational Research award, University of Puerto Rico Medical Sciences Campus) from the National Institute on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMHD or NIH.

Consortium Institutions

The Puerto Rico Clinical and Translational Research Consortium is a collaborative project of the the University of Puerto Rico Medical Sciences Campus, Universidad Central del Caribe and Ponce School of Medicine and Health Sciences.